Janis R A, Sarmiento J G, Maurer S C, Bolger G T, Triggle D J
J Pharmacol Exp Ther. 1984 Oct;231(1):8-15.
This study was carried out to characterize [3H]nitrendipine binding to cardiac membranes and to test the hypothesis that high affinity binding of Ca++ channel antagonists and agonists is to Ca++ channels. Binding was specific, rapid, reversible and stereoselective. The relative order of potency of nifedipine analogs for inhibition of binding was the same as that for inhibition of smooth and cardiac muscle contraction. Results with diltiazem, verapamil and lidoflazine were consistent with the hypothesis that nondihydropyridine Ca++ channel antagonists act at one or more sites allosterically linked to the 1,4-dihydropyridine site in cardiac cells. The Ca++ channel agonist Bay K 8644 [methyl-1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyr idine- 5-carboxylate] displaced specifically bound [3H]nitrendipine in an apparently competitive manner with an IC50 value of 5 nM. The results suggest that organic antagonists do not act by physically blocking the Ca++ channel. The data also support the hypothesis that the high affinity binding sites for [3H]nitrendipine in isolated cardiac membranes are associated with Ca++ channels that are inactivated or are otherwise unavailable for opening.
本研究旨在表征[3H]尼群地平与心肌膜的结合情况,并检验钙通道拮抗剂和激动剂的高亲和力结合位点是钙通道这一假说。结合具有特异性、快速性、可逆性和立体选择性。硝苯地平类似物抑制结合的效力相对顺序与抑制平滑肌和心肌收缩的顺序相同。地尔硫卓、维拉帕米和利多氟嗪的结果与非二氢吡啶类钙通道拮抗剂作用于心肌细胞中与1,4 - 二氢吡啶位点变构连接的一个或多个位点这一假说一致。钙通道激动剂Bay K 8644 [甲基 - 1,4 - 二氢 - 2,6 - 二甲基 - 3 - 硝基 - 4 - (2 - 三氟甲基苯基) - 吡啶 - 5 - 羧酸盐]以明显竞争性方式特异性取代结合的[3H]尼群地平,IC50值为5 nM。结果表明有机拮抗剂并非通过物理性阻断钙通道起作用。数据还支持这样的假说,即分离的心肌膜中[3H]尼群地平的高亲和力结合位点与失活或无法开放的钙通道相关。